Abisola Idu, MS, MPH

Abisola Idu

“I apply well-established and innovative statistical methods to clinical and public health research. My objective is to support, challenge, or capture new findings that influence decisions that can improve health and health care, worldwide."

Abisola Idu, MS, MPH

Collaborative Biostatistician I, Kaiser Permanente Washington Health Research Institute

Abisola.Idu@kp.org
206-287-2893

Biography

Biostatistician Abisola Idu, MS, MPH, is interested in research that investigates the effectiveness and efficacy of treatment in pharmacoepidemiologic studies. She has a broad range of interest in research with a strong motivation to investigate the health challenges of malaria, obesity, cancer, heart disease, and maternal health.

Ms. Idu began her contributions to clinical and public health research through her academic training at the University of Texas Health Science Center, School of Public Health. She further got rigorous research experience by being a part of the leukemia, lymphoma, and cancer prevention research team at The University of Texas M.D. Anderson Cancer Center in 2015. She has been a biostatistician at Kaiser Permanente Washington Health Research Institute's Biostatistics Unit since 2018.

Ms. Idu looks forward to using her expertise in application of epidemiological principles and surveillance methodologies at KPWHRI. She has an in-depth knowledge of the ICH-GCP, FDA, IRB policies, regulations, and guidelines and plans to use her skills and background to implement epidemiologic study designs in clinical research studies.

Research interests and experience

  • Cancer

    Efficacy and safety of therapies; association between genetic variability and survival outcomes

  • Obesity 

    Role of nutritional, psychological and lifestyle factors; obesity prevention and control

  • Heart Disease

    Role of aging, nutritional and lifestyle factors; Intervention strategies for prevention and disease control

  • Maternal Health

    Association between social, behavioral and clinical factors and maternal and infant outcomes

  • Malaria

    Malaria prevention and control; development of vaccines; availability and accessibility to malaria treatment

  • Women's Health

  • Mental Health

  • Biostatistics

  • Social Determinants of Health

  • Vaccines & Infectious Diseases

  • Cardiovascular Health

Recent publications

Penfold RB, Idu AE, Coley RY, Cushing-Haugen KL, King D, Glass A, Phillips RC, Renz AD, Pabiniak CJ, Graham VF, Thompson EE, Ralston JD, Simon GE, Gonzalez ES, Myers KM, Beck A, Quintana LM, Runkle AJ, Rogers M, Foster DM, Clarke GN, Massimino S, Crawford PM, Cavese JA, Cordaro AR, Chavez LI, Kelleher KJ, Schwartz N, Jiner KR, Liu SB, Condrac S, Hilt RJ. Safer and targeted use of antipsychotics in youth: an embedded, pragmatic randomized trial. J Child Psychol Psychiatry. 2024 Oct 29. doi: 10.1111/jcpp.14059. Epub ahead of print]. PubMed

Mogk J, Idu AE, Bobb JF, Key D, Wong ES, Palazzo L, Stefanik-Guizlo K, King D, Beatty T, Dorsey CN, Caldeiro RM, Garza McWethy A, Glass JE. Prescription digital therapeutics for substance use disorder in primary care: mixed methods evaluation of a pilot implementation study. JMIR Form Res. 2024;8:e59088. doi: 10.2196/59088.  PubMed

Bobb JF, Idu AE, Qiu H, Yu O, Boudreau DM, Wartko PD, Matthews AG, McCormack J, Lee AK, Campbell CI, Saxon AJ, Liu DS, Altschuler A, Samet JH, Northrup TF, Braciszewski JM, Murphy MT, Arnsten JH, Cunningham CO, Horigian VE, Szapocznik J, Glass JE, Caldeiro RM, Tsui JI, Burganowski RP, Weinstein ZM, Murphy SM, Hyun N, Bradley KA. Offering nurse care management for opioid use disorder in primary care: Impact on emergency and hospital utilization in a cluster-randomized implementation trial.  Drug Alcohol Depend. 2024;261:111350. doi: 10.1016/j.drugalcdep.2024.111350. Epub 2024 Jun 10.  PubMed

Rosenberg DE, Wu Y, Idu A, Greenwood-Hickman MA, McCurry SM, LaCroix AZ, Shaw PA. Historic cognitive function trajectories as predictors of sedentary behavior and physical activity in older adults. J Gerontol A Biol Sci Med Sci. 2024;79(7):glae125. doi: 10.1093/gerona/glae125.  PubMed

Dublin S, Greenwood-Hickman MA, Karliner L, Hsu C, Coley RY, Colemon L, Carrasco A, King D, Grace A, Lee SJ, Walsh JME, Barrett T, Broussard J, Singh U, Idu A, Yaffe K, Boustani M, Barnes DE. The electronic health record Risk of Alzheimer's and Dementia Assessment Rule (eRADAR) Brain Health Trial: Protocol for an embedded, pragmatic clinical trial of a low-cost dementia detection algorithm.  Contemp Clin Trials. 2023;135:107356. doi: 10.1016/j.cct.2023.107356. Epub 2023 Oct 17.  PubMed

Wartko PD, Bobb JF, Boudreau DM, Matthews AG, McCormack J, Lee AK, Qiu H, Yu O, Hyun N, Idu AE, Campbell CI, Saxon AJ, Liu DS, Altschuler A, Samet JH, Labelle CT, Zare-Mehrjerdi M, Stotts AL, Braciszewski JM, Murphy MT, Dryden D, Arnsten JH, Cunningham CO, Horigian VE, Szapocznik J, Glass JE, Caldeiro RM, Phillips RC, Shea M, Bart G, Schwartz RP, McNeely J, Liebschutz JM, Tsui JI, Merrill JO, Lapham GT, Addis M, Bradley KA; PROUD Trial Collaborators; Ghiroli MM, Hamilton LK, Hu Y, LaHue JS, Loree AM, Murphy SM, Northrup TF, Shmueli-Blumberg D, Silva AJ, Weinstein ZM, Wong MT, Burganowski RP. Nurse care management for opioid use disorder treatment: The PROUD cluster randomized clinical trial. JAMA Intern Med. 2023 Oct 30:e235701. doi: 10.1001/jamainternmed.2023.5701. [Epub ahead of print]. PubMed

 

Research

PROUD_trial_1col.jpg

Increasing opioid use disorder treatment in primary care

A trial led by KPWHRI researchers found that adding nurse care managers helped more people get needed treatment.

Research

Female doctor and senior female patient sitting around desk

Dementia risk screening tool shows promise

In a new study, a tool to help discover undiagnosed dementia performed well in 2 separate health systems.

Research

Hypertension-in-pregnancy_1col.jpg

New findings on treating hypertension in pregnancy

A study led by Dr. Sascha Dublin finds similar outcomes for 3 hypertension medications, filling an evidence gap.

COVID-19

Shortreed-COVID-19-disparities-paper_1col.jpg

Greater infection risks linked to COVID-19 disparities

New work by Susan Shortreed, PhD, finds infection risks drive worse outcomes for some racial and ethnic groups.